10 Einträge gefunden

1. Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)

   1. Vermehren, Johannes
   2. Serfert, Yvonne
   3. Cornberg, Markus
   4. Stoehr, Albrecht
   5. Klinker, Hartwig
   6. Simon, Karl-Georg
   7. Teuber, Gerlinde

   2020 - Forschungsinformationssystem des UKE
2. Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance-associated substitutions

   1. Dietz, Julia
   2. Vermehren, Johannes
   3. Matschenz, Katrin
   4. Buggisch, Peter
   5. Klinker, Hartwig
   6. Schulze Zur Wiesch, Julian
   7. Hinrichsen, Holger

   2020 - Forschungsinformationssystem des UKE
3. Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

   1. Schäfer, Guido
   2. Hoffmann, Christian
   3. Arasteh, Keikawus
   4. Schürmann, Dirk
   5. Stephan, Christoph
   6. Jensen, Björn
   7. Stoll, Matthias

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R)

   1. Christensen, Stefan
   2. Buggisch, Peter
   3. Mauss, Stefan
   4. Böker, Klaus Hw
   5. Müller, Tobias
   6. Klinker, Hartwig
   7. Zimmermann, Tim

   2019 - Forschungsinformationssystem des UKE
5. Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV) an open-label, single-arm, phase 2 study

   1. Deterding, Katja
   2. Spinner, Christoph D
   3. Schott, Eckart
   4. Welzel, Tania M
   5. Gerken, Guido
   6. Klinker, Hartwig
   7. Spengler, Ulrich

   2017 - Forschungsinformationssystem des UKE
6. Aktuelle Aspekte zur HCV-Triple-Therapie bei Suchtpatienten

   1. Backmund, Markus
   2. Forestier, Nicole
   3. Isernhagen, Konrad
   4. Klinker, Hartwig
   5. Naumann, Uwe
   6. Reimer, Jens
   7. Teuber, Gerlinde

   2012 - Forschungsinformationssystem des UKE
7. Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks.

   1. Sarrazin, Christoph
   2. Schwendy, Susanne
   3. Möller, Bernd
   4. Dikopoulos, Nektarios
   5. Buggisch, Peter
   6. Encke, Jens
   7. Teuber, Gerlinde

   2011 - Forschungsinformationssystem des UKE
8. The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection.

   1. Weich, Viola
   2. Herrmann, Eva
   3. Chung, Tje Lin
   4. Sarrazin, Christoph
   5. Hinrichsen, Holger
   6. Buggisch, Peter
   7. Gerlach, Tilman

   2011 - Forschungsinformationssystem des UKE
9. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.

   1. Berg, Thomas
   2. Weich, Viola
   3. Teuber, Gerlinde
   4. Klinker, Hartwig
   5. Möller, Bernd
   6. Rasenack, Jens
   7. Hinrichsen, Holger

   2009 - Forschungsinformationssystem des UKE
10. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

    1. Halangk, Juliane
    2. Sarrazin, Christoph
    3. Neumann, Konrad
    4. Puhl, Gero
    5. Mueller, Tobias
    6. Teuber, Gerlinde
    7. Klinker, Hartwig

    2008 - Forschungsinformationssystem des UKE